Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Natural Killer Cell Dysfunction in Premenopausal BRCA1 Mutation Carriers: A Potential Mechanism for Ovarian Carcinogenesis.
Haran S, Chindera K, Sabry M, Wilkinson N, Arora R, Zubiak A, Bartlett TE, Evans I, Jones A, Reisel D, Herzog C, Alkasalias T, Newman M, Kim J, Rådestad AF, Gemzell-Danielsson K, Rosenthal AN, Dubeau L, Lowdell MW, Widschwendter M. Haran S, et al. Among authors: rosenthal an. Cancers (Basel). 2024 Mar 18;16(6):1186. doi: 10.3390/cancers16061186. Cancers (Basel). 2024. PMID: 38539519 Free PMC article.
The sex hormone system in carriers of BRCA1/2 mutations: a case-control study.
Widschwendter M, Rosenthal AN, Philpott S, Rizzuto I, Fraser L, Hayward J, Intermaggio MP, Edlund CK, Ramus SJ, Gayther SA, Dubeau L, Fourkala EO, Zaikin A, Menon U, Jacobs IJ. Widschwendter M, et al. Among authors: rosenthal an. Lancet Oncol. 2013 Nov;14(12):1226-32. doi: 10.1016/S1470-2045(13)70448-0. Epub 2013 Oct 17. Lancet Oncol. 2013. PMID: 24140203 Free article.
Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers.
Widschwendter M, Burnell M, Fraser L, Rosenthal AN, Philpott S, Reisel D, Dubeau L, Cline M, Pan Y, Yi PC, Gareth Evans D, Jacobs IJ, Menon U, Wood CE, Dougall WC. Widschwendter M, et al. Among authors: rosenthal an. EBioMedicine. 2015 Sep 9;2(10):1331-9. doi: 10.1016/j.ebiom.2015.08.037. eCollection 2015 Oct. EBioMedicine. 2015. PMID: 26629528 Free PMC article.
Aberrant regulation of RANKL/OPG in women at high risk of developing breast cancer.
Kiechl S, Schramek D, Widschwendter M, Fourkala EO, Zaikin A, Jones A, Jaeger B, Rack B, Janni W, Scholz C, Willeit J, Weger S, Mayr A, Teschendorff A, Rosenthal A, Fraser L, Philpott S, Dubeau L, Keshtgar M, Roylance R, Jacobs IJ, Menon U, Schett G, Penninger JM. Kiechl S, et al. Oncotarget. 2017 Jan 17;8(3):3811-3825. doi: 10.18632/oncotarget.14013. Oncotarget. 2017. PMID: 28002811 Free PMC article.
Plasma cell-free DNA methylation analysis for ovarian cancer detection: Analysis of samples from a case-control study and an ovarian cancer screening trial.
Herzog C, Jones A, Evans I, Reisel D, Olaitan A, Doufekas K, MacDonald N, Rådestad AF, Gemzell-Danielsson K, Zikan M, Cibula D, Dostálek L, Paprotka T, Leimbach A, Schmitt M, Ryan A, Gentry-Maharaj A, Apostolidou S, Rosenthal AN, Menon U, Widschwendter M. Herzog C, et al. Among authors: rosenthal an. Int J Cancer. 2024 Feb 15;154(4):679-691. doi: 10.1002/ijc.34757. Epub 2023 Oct 20. Int J Cancer. 2024. PMID: 37861205
High performance of the DNA methylation-based WID-qEC test for detecting uterine cancers independent of sampling modalities.
Illah O, Scott M, Redl E, Barrett JE, Schreiberhuber L, Herzog C, Vavourakis CD, Jones A, Evans I, Reisel D, Chandrasekaran D, Doufekas K, Graham R, Kotsopoulos IC, MacDonald N, Arora R, Olaitan A, Rosenthal A, Widschwendter M. Illah O, et al. Int J Cancer. 2024 May 13. doi: 10.1002/ijc.35000. Online ahead of print. Int J Cancer. 2024. PMID: 38739012
Screening for ovarian cancer.
Rosenthal AN, Menon U, Jacobs IJ. Rosenthal AN, et al. Clin Obstet Gynecol. 2006 Sep;49(3):433-47. doi: 10.1097/00003081-200609000-00004. Clin Obstet Gynecol. 2006. PMID: 16885651 Review.
The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome.
Crosbie EJ, Ryan NAJ, Arends MJ, Bosse T, Burn J, Cornes JM, Crawford R, Eccles D, Frayling IM, Ghaem-Maghami S, Hampel H, Kauff ND, Kitchener HC, Kitson SJ, Manchanda R, McMahon RFT, Monahan KJ, Menon U, Møller P, Möslein G, Rosenthal A, Sasieni P, Seif MW, Singh N, Skarrott P, Snowsill TM, Steele R, Tischkowitz M; Manchester International Consensus Group; Evans DG. Crosbie EJ, et al. Genet Med. 2019 Oct;21(10):2390-2400. doi: 10.1038/s41436-019-0489-y. Epub 2019 Mar 28. Genet Med. 2019. PMID: 30918358 Free PMC article.
79 results